European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)

NCT02773836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6036

Last updated 2019-06-03

Study results available
· View outcomes & findings →

Summary

The main objective of EUREST-PLUS is to monitor and evaluate the impact of the Tobacco Products Directive (TPD) within the context of FCTC ratification at an EU level. The investigators specific objectives, within WorkPackage 2 and Workpackage 3 are: To evaluate the psychosocial and behavioral impact of TPD implementation and FCTC implementation, through the creation of a cohort study of adult smokers in 6 European Member States (EU MS), Germany, Greece, Hungary, Poland, Romania, Spain; (total n=6000) in a pre- vs. post-TPD study design.

EUREST-PLUS is funded through the European Union's Horizon 2020 research and innovation programme under grant agreement No 681109

Conditions

  • Tobacco Dependence

Interventions

OTHER

Questionnaire

Questionnaire: To evaluate the impact of the implementation of the EU Tobacco Products Directive (TPD) and Framework Convention on Tobacco Control (FCTC)

Sponsors & Collaborators

  • King's College London

    collaborator OTHER
  • German Cancer Research Center

    collaborator OTHER
  • Maastricht University

    collaborator OTHER
  • University of Athens

    collaborator OTHER
  • AER PUR ROMANIA

    collaborator UNKNOWN
  • European Respiratory Society

    collaborator OTHER
  • University of Waterloo

    collaborator OTHER
  • Institut Català d'Oncologia

    collaborator OTHER
  • DOHANYZAS VAGY EGESZSEG MAGYAR ALAPITVANY

    collaborator UNKNOWN
  • PROMOCJA ZDROWIA - ZDROWIE ALBO TYTON FUNDACJA

    collaborator UNKNOWN
  • University of Crete

    collaborator OTHER
  • TNS OPINION SA

    collaborator UNKNOWN
  • European Network For Smoking and Tobacco Prevention

    lead OTHER

Principal Investigators

  • Constantine Vardavas, MD,RN,MPH,PHD · European Network For Smoking and Tobacco Prevention

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-15
Primary Completion
2016-09-12
Completion
2018-05-06

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02773836 on ClinicalTrials.gov